$0.72
+0.00 (+0.03%)
GOVX News2 articles
GeoVax Shares Surge on Biodefense Funding and Ebola Alert
GeoVax Labs shares surged nearly 80% after announcing a $3 million private placement, riding a wave of biodefense interest sparked by WHO's Ebola emergency in Africa.
GeoVax Shares Surge Pre-Market on Mpox Vaccine Trial Plans
GeoVax Labs shares surged pre-market Monday after announcing plans for a Phase 3 trial of its GEO-MVA mpox vaccine, though cash and funding risks remain key issues.